SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-366358
Filing Date
2021-12-23
Accepted
2021-12-23 17:18:01
Documents
16
Period of Report
2021-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d203387d8k.htm   iXBRL 8-K 29522
2 EX-1.1 d203387dex11.htm EX-1.1 175377
3 EX-5.1 d203387dex51.htm EX-5.1 22271
7 GRAPHIC g203387dsp006.jpg GRAPHIC 8820
8 GRAPHIC g203387dsp05.jpg GRAPHIC 42673
  Complete submission text file 0001193125-21-366358.txt   479648

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prta-20211223.xsd EX-101.SCH 2518
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20211223_lab.xml EX-101.LAB 18571
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20211223_pre.xml EX-101.PRE 11628
10 EXTRACTED XBRL INSTANCE DOCUMENT d203387d8k_htm.xml XML 3602
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 211517986
SIC: 2834 Pharmaceutical Preparations